文献速递传染病防控与疫情报告卫生政策与健康促进

全基因组测序用于病原体鉴定与监测的经济学评价:欧洲和美洲案例研究结果(2016-2019)

Economic evaluation of whole genome sequencing for pathogen identification and surveillance - results of case studies in Europe and the Americas 2016 to 2019.
PubMed 文献 · Euro Surveill · 2021-01-01

该研究通过欧洲和美洲八个参考实验室的案例研究,从机构视角评估常规全基因组测序(WGS)用于病原体鉴定与监测的成本与效益。每样本WGS成本为常规方法的1.2至4.3倍,但需预防0.2%至1.1%(平均0.7%)的沙门菌病病例即可实现成本平衡。结论认为有效使用WGS时其额外信息价值超过额外成本。

要点

  • 每样本WGS成本为常规方法的1.2至4.3倍,但带来病原鉴定与监测的重大效益。
  • 沙门菌监测中,预防0.2%至1.1%(平均0.7%)的报告病例即可抵消WGS额外成本。
  • WGS成本差异源于规模经济、自动化程度、测序技术及设备耗材折扣和产能利用度。

核心结论

  • 即使按本文记录的成本水平,有效使用WGS提供的额外信息价值超过其额外成本。

研究设计与样本

  • 在歐洲和美洲八个参考实验室开展案例研究,涵盖禽流感(2个)、人流感(1个)和食源性病原体(5个)监测。
  • 从机构视角基于确定参考期(多覆盖2017年至少部分时段)的成本与效益评估WGS相对于常规方法的投资案例。
  • 采用盈亏平衡分析估算通过WGS需避免的疾病病例数(以沙门菌监测为例)以实现成本平衡。

主要发现

  • 每样本WGS成本为常规方法的1.2至4.3倍。
  • WGS为病原鉴定与监测带来重大效益,显著改变实验室工作流程、分析过程及暴发检测与控制。
  • 需预防0.2%至1.1%(平均0.7%)的报告沙门菌病病例以平衡WGS额外成本。

关键数值与推荐

  • 每样本WGS成本为常规方法的1.2至4.3倍。
  • 沙门菌监测盈亏平衡需预防0.2%至1.1%(平均0.7%)的报告病例。

临床怎么用

  • 参考实验室在决定是否实施WGS时,可参考本研究的成本效益框架与盈亏平衡分析方法。
  • 需考虑规模经济、自动化程度、测序技术选择及设备耗材折扣对WGS成本的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundWhole genome sequencing (WGS) is increasingly used for pathogen identification and surveillance.AimWe evaluated costs and benefits of routine WGS through case studies at eight reference laboratories in Europe and the Americas which conduct pathogen surveillance for avian influenza (two laboratories), human influenza (one laboratory) and food-borne pathogens (five laboratories).MethodsThe evaluation focused on the institutional perspective, i.e. the 'investment case' for implementing WGS compared with conventional methods, based on costs and benefits during a defined reference period, mostly covering at least part of 2017. A break-even analysis estimated the number of cases of illness (for the example of Salmonella surveillance) that would need to be avoided through WGS in order to 'break even' on costs.ResultsOn a per-sample basis, WGS was between 1.2 and 4.3 times more expensive than routine conventional methods. However, WGS brought major benefits for pathogen identification and surveillance, substantially changing laboratory workflows, analytical processes and outbreaks detection and control. Between 0.2% and 1.1% (on average 0.7%) of reported salmonellosis cases would need to be prevented to break even with respect to the additional costs of WGS.ConclusionsEven at cost levels documented here, WGS provides a level of additional information that more than balances the additional costs if used effectively. The substantial cost differences for WGS between reference laboratories were due to economies of scale, degree of automation, sequencing technology used and institutional discounts for equipment and consumables, as well as the extent to which sequencers are used at full capacity.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Alleweldt F, Kara Ş, Best K, et al. Economic evaluation of whole genome sequencing for pathogen identification and surveillance - results of case studies in Europe and the Americas 2016 to 2019. Euro Surveill. 2021. PMID: 33663647. doi:10.2807/1560-7917.ES.2021.26.9.1900606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。